Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA Sets FY 2021 User Fees, With Coronavirus (Somewhat) In Mind
Aug 01 2020
•
By
Derrick Gingery
The FDA only mentioned the coronavirus pandemic only in the description of its FY 2021 prescription drug user fee calculations. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from User Fees
More from Pathways & Standards